Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 254640, 19 pages
http://dx.doi.org/10.1155/2014/254640
Research Article

Feed-Forward Inhibition of CD73 and Upregulation of Adenosine Deaminase Contribute to the Loss of Adenosine Neuromodulation in Postinflammatory Ileitis

1Laboratório de Farmacologia e Neurobiologia, UMIB and MedInUP, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto (UP), L. Prof. Abel Salazar 2, 4099-033 Porto, Portugal
2Centre de Recherche du CHU de Québec, CHUL, Québec, QC, Canada G1V 4G2
3Département de Microbiologie-Infectiologie et d’Immunologie, Faculté de Médecine, Université Laval, Québec, QC, Canada G1V 0A6

Received 1 May 2014; Revised 14 July 2014; Accepted 15 July 2014; Published 19 August 2014

Academic Editor: Mireia Martín-Satué

Copyright © 2014 Cátia Vieira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. A. Sharkey and B. A. Kroese, “Consequences of intestinal inflammation on the enteric nervous system: neuronal activation induced by inflammatory mediators,” Anatomical Record, vol. 262, pp. 79–90, 2001. View at Google Scholar
  2. V. Vasina, G. Barbara, L. Talamonti et al., “Enteric neuroplasticity evoked by inflammation,” Autonomic Neuroscience, vol. 126-127, pp. 264–272, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Pontell, P. Castelucci, M. Bagyánszki et al., “Structural changes in the epithelium of the small intestine and immune cell infiltration of enteric ganglia following acute mucosal damage and local inflammation,” Virchows Archiv, vol. 455, no. 1, pp. 55–65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Roberts, M. K. Lukewich, K. A. Sharkey, J. B. Furness, G. M. Mawe, and A. E. Lomax, “The roles of purinergic signaling during gastrointestinal inflammation,” Current Opinion in Pharmacology, vol. 12, no. 6, pp. 659–666, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Kukulski, SA. Lévesque, and J. Sévigny, “Impact of ectoenzymes on P2 and P1 receptor signaling,” Advances in Pharmacology, vol. 61, pp. 263–299, 2011. View at Google Scholar
  6. T. D. White and R. A. Leslie, “Depolarization-induced release of adenosine 5'-triphosphate from isolated varicosities derived from the myenteric plexus of the guinea pig intestine,” Journal of Neuroscience, vol. 2, no. 2, pp. 206–215, 1982. View at Google Scholar · View at Scopus
  7. K. Nitahara, A. Kittel, S. D. Liang, and E. S. Vizi, “A1-Receptor-mediated effect of adenosine on the release of acetylcholine from the myenteric plexus: Role and localization of ecto-ATPase and 5′-nucleotidase,” Neuroscience, vol. 67, no. 1, pp. 159–168, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Kukulski, S. A. Lévesque, É. G. Lavoie et al., “Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8,” Purinergic Signalling, vol. 1, no. 2, pp. 193–204, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Stefan, S. Jansen, and M. Bollen, “NPP-type ectophosphodiesterases: unity in diversity,” Trends in Biochemical Sciences, vol. 30, no. 10, pp. 542–550, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. F. P. Gendron, O. Benrezzak, B. W. Krugh, Q. Kong, G. A. Weisman, and A. R. Beaudoin, “Purine signaling and potential new therapeutic approach: possible outcomes of NTPDase inhibition,” Current Drug Targets, vol. 3, no. 3, pp. 229–245, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Sträter, “Ecto-5′-nucleotidase: structure function relationships,” Purinergic Signalling, vol. 2, no. 2, pp. 343–350, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Duarte-Araújo, C. Nascimento, M. A. Timóteo, M. T. Magalhães-Cardoso, and P. Correia-de-Sá, “Relative contribution of ecto-ATPase and ecto-ATPDase pathways to the biphasic effect of ATP on acetylcholine release from myenteric motoneurons,” British Journal of Pharmacology, vol. 156, no. 3, pp. 519–533, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Milusheva, B. Sperlagh, B. Kiss et al., “Inhibitory effect of hypoxic condition on acetylcholine release is partly due to the effect of adenosine released from the tissue,” Brain Research Bulletin, vol. 24, no. 3, pp. 369–373, 1990. View at Publisher · View at Google Scholar · View at Scopus
  14. J. G. de Man, T. C. Seerden, B. Y. de Winter, E. A. van Marck, A. G. Herman, and P. A. Pelckmans, “Alteration of the purinergic modulation of enteric neurotransmission in the mouse ileum during chronic intestinal inflammation,” British Journal of Pharmacology, vol. 139, no. 1, pp. 172–184, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Nicholls, V. R. Brownhill, and S. M. O. Hourani, “Characterization of P1-purinoceptors on rat isolated duodenum longitudinal muscle and muscularis mucosae,” British Journal of Pharmacology, vol. 117, no. 1, pp. 170–174, 1996. View at Google Scholar · View at Scopus
  16. C. Vieira, F. Ferreirinha, I. Silva, M. Duarte-Araújo, and P. Correia-de-Sá, “Localization and function of adenosine receptor subtypes at the longitudinal muscle-myenteric plexus of the rat ileum,” Neurochemistry International, vol. 59, no. 7, pp. 1043–1055, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. N. A. Moneta, T. J. McDonald, and M. A. Cook, “Endogenous adenosine inhibits evoked substance P release from perifused networks of myenteric ganglia,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 272, no. 1, pp. G38–G45, 1997. View at Google Scholar · View at Scopus
  18. M. Duarte-Araújo, C. Nascimento, M. A. Timóteo, T. Magalhães-Cardoso, and P. Correia-de-Sá, “Dual effects of adenosine on acetylcholine release from myenteric motoneurons are mediated by junctional facilitatory A2A and extrajunctional inhibitory A1 receptors,” British Journal of Pharmacology, vol. 141, no. 6, pp. 925–934, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Correia-de-Sá, S. Adães, M. A. Timóteo et al., “Fine-tuning modulation of myenteric motoneurons by endogenous adenosine: on the role of secreted adenosine deaminase,” Autonomic Neuroscience: Basic and Clinical, vol. 126-127, pp. 211–224, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Pettengill, S. Robson, M. Tresenriter et al., “Soluble ecto-5′-nucleotidase (5′-NT), alkaline phosphatase, and adenosine deaminase (ADA1) activities in neonatal blood favor elevated extracellular adenosine,” The Journal of Biological Chemistry, vol. 288, no. 38, pp. 27315–27326, 2013. View at Publisher · View at Google Scholar
  21. R. Franco, V. Casadó, F. Ciruela et al., “Cell surface adenosine deaminase: much more than an ectoenzyme,” Progress in Neurobiology, vol. 52, no. 4, pp. 283–294, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. D. L. Marquardt, H. E. Gruber, and S. I. Wasserman, “Adenosine release from stimulated mast cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 19I, pp. 6192–6196, 1984. View at Google Scholar · View at Scopus
  23. R. H. Stead, M. F. Dixon, N. H. Bramwell, R. H. Riddell, and J. Bienenstock, “Mast cells are closely apposed to nerves in the human gastrointestinal mucosa,” Gastroenterology, vol. 97, no. 3, pp. 575–585, 1989. View at Google Scholar · View at Scopus
  24. J. Bogers, T. Moreels, J. de Man et al., “Schistosoma mansoni causing diffuse enteric inflammation and damage of the enteric nervous system in the mouse small intestine,” Neurogastroenterology & Motility, vol. 12, pp. 431–440, 2000. View at Google Scholar
  25. L. Antonioli, M. Fornai, R. Colucci et al., “Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications,” Pharmacology and Therapeutics, vol. 120, no. 3, pp. 233–253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. A. E. Jergens, “Inflammatory bowel disease. Current perspectives,” Veterinary Clinics of North America-Small Animal Practice, vol. 29, no. 2, pp. 501–521, 1999. View at Google Scholar · View at Scopus
  27. M. A. Engel, C. A. Kellermann, T. Rau, G. Burnat, E. G. Hahn, and P. C. Konturek, “Ulcerative colitis in AKR mice is attenuated by intraperitoneally administered anandamide,” Journal of Physiology and Pharmacology, vol. 59, no. 4, pp. 673–689, 2008. View at Google Scholar · View at Scopus
  28. S. Wirtz and M. F. Neurath, “Mouse models of inflammatory bowel disease,” Advanced Drug Delivery Reviews, vol. 59, no. 11, pp. 1073–1083, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. W. D. Paton and E. S. Vizi, “The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip,” British Journal of Pharmacology, vol. 35, no. 1, pp. 10–28, 1969. View at Google Scholar · View at Scopus
  30. M. Costa, S. J. H. Brookes, P. A. Steele, I. Gibbins, E. Burcher, and C. J. Kandiah, “Neurochemical classification of myenteric neurons in the guinea-pig ileum,” Neuroscience, vol. 75, no. 3, pp. 949–967, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. A. R. Pinheiro, D. Paramos-de-Carvalho, M. Certal et al., “Histamine induces ATP release from human subcutaneous fibroblasts, via pannexin-1 hemichannels, leading to Ca2+ mobilization and cell proliferation,” The Journal of Biological Chemistry, vol. 288, pp. 27571–27583, 2013. View at Google Scholar
  32. M. A. Timóteo, I. Carneiro, I. Silva et al., “ATP released via pannexin-1 hemichannels mediates bladder overactivity triggered by urothelial P2Y6 receptors,” Biochemical Pharmacology, vol. 87, pp. 371–379, 2014. View at Google Scholar
  33. K. Enjyoji, J. Sévigny, Y. Lin et al., “Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation,” Nature Medicine, vol. 5, no. 9, pp. 1010–1017, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Heine, N. Braun, J. Sévigny, S. C. Robson, J. Servos, and H. Zimmermann, “The C-terminal cysteine-rich region dictates specific catalytic properties in chimeras of the ectonucleotidases NTPDase1 and NTPDase2,” European Journal of Biochemistry, vol. 268, no. 2, pp. 364–373, 2001. View at Publisher · View at Google Scholar
  35. M. MartínSatué, E. G. Lavoie, J. Pelletier et al., “Localization of plasma membrane bound NTPDases in the murine reproductive tract,” Histochemistry and Cell Biology, vol. 131, pp. 615–628, 2009. View at Google Scholar
  36. D. L. Bartel, S. L. Sullivan, É. G. Lavoie, J. Sévigny, and T. E. Finger, “Nucleoside triphosphate diphosphohydrolase-2 is the ecto-ATPase of type I cells in taste buds,” Journal of Comparative Neurology, vol. 497, no. 1, pp. 1–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Fausther, J. Lecka, F. Kukulski et al., “Cloning, purification, and identification of the liver canalicular ecto-ATPase as NTPDase8,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 292, no. 3, pp. G785–G795, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. T. G. Moreels, J. G. De Man, J. M. C. Dick et al., “Effect of TNBS-induced morphological changes on pharmacological contractility of the rat ileum,” European Journal of Pharmacology, vol. 423, no. 2-3, pp. 211–222, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. I. Depoortere, T. Thijs, and T. L. Peeters, “Generalized loss of inhibitory innervation reverses serotonergic inhibition into excitation in a rabbit model of TNBS-colitis,” British Journal of Pharmacology, vol. 135, no. 8, pp. 2011–2019, 2002. View at Google Scholar · View at Scopus
  40. D. S. Strong, C. F. Cornbrooks, J. A. Roberts, J. M. Hoffman, K. A. Sharkey, and G. M. Mawe, “Purinergic neuromuscular transmission is selectively attenuated in ulcerated regions of inflamed guinea pig distal colon,” Journal of Physiology, vol. 588, no. 5, pp. 847–859, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Odashima, G. Bamias, J. Rivera-Nieves et al., “Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease,” Gastroenterology, vol. 129, no. 1, pp. 26–33, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. I. C. Cavalcante, M. V. Castro, A. R. F. Barreto et al., “Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis,” Infection and Immunity, vol. 74, no. 5, pp. 2606–2612, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Antonioli, M. Fornai, R. Colucci et al., “Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis,” European Journal of Pharmacology, vol. 650, no. 2-3, pp. 639–649, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Antonioli, P. Pacher, E. S. Vizi, and G. Haskó, “CD39 and CD73 in immunity and inflammation,” Trends in Molecular Medicine, vol. 19, no. 6, pp. 355–367, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Neshat, M. Devries, A. R. Barajas-Espinosa, L. Skeith, S. P. Chisholm, and A. E. Lomax, “Loss of purinergic vascular regulation in the colon during colitis is associated with upregulation of CD39,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 296, no. 2, pp. G399–G405, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. M. C. Giron, A. Bin, P. Brun et al., “Cyclic AMP in rat ileum: evidence for the presence of an extracellular cyclic AMP-adenosine pathway,” Gastroenterology, vol. 134, no. 4, pp. 1116–1126, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. M. T. Magalhães-Cardoso, M. F. Pereira, L. Oliveira, J. A. Ribeiro, R. A. Cunha, and P. Correia-de-Sá, “Ecto-AMP deaminase blunts the ATP-derived adenosine A2A receptor facilitation of acetylcholine release at rat motor nerve endings,” Journal of Physiology, vol. 549, no. 2, pp. 399–408, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. N. Braun, J. Sévigny, S. C. Robson, K. Hammer, M. Hanani, and H. Zimmermann, “Association of the ecto -ATPase NTPDase2 with glial cells of the peripheral nervous system,” GLIA, vol. 45, no. 2, pp. 124–132, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. E. G. Lavoie, B. D. Gulbransen, M. Martín-Satué, E. Aliagas, K. A. Sharkey, and J. Sévigny, “Ectonucleotidases in the digestive system: focus on NTPDase3 localization,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 300, no. 4, pp. G608–G620, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Martin, J. Huguet, J. J. Centelles, and R. Franco, “Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex: possible role of adenosine deaminase as costimulatory molecule,” The Journal of Immunology, vol. 155, no. 10, pp. 4630–4643, 1995. View at Google Scholar · View at Scopus
  51. B. A. Conlon and W. R. Law, “Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses,” Clinical and Experimental Immunology, vol. 138, no. 1, pp. 14–20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. S. E. Lakhan and A. Kirchgessner, “Neuroinflammation in inflammatory bowel disease,” Journal of Neuroinflammation, vol. 7, article 37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Antonioli, M. Fornai, R. Colucci et al., “The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors,” Journal of Pharmacology and Experimental Therapeutics, vol. 335, no. 2, pp. 434–442, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. S. C. Robson, J. Sévigny, and H. Zimmermann, “The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance,” Purinergic Signalling, vol. 2, no. 2, pp. 409–430, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. N. A. Louis, A. M. Robinson, C. F. MacManus, J. Karhausen, M. Scully, and S. P. Colgan, “Control of IFN-αA by CD73: implications for mucosal inflammation,” The Journal of Immunology, vol. 180, no. 6, pp. 4246–4255, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. I. Sotnikov and N. A. Louis, “CD73-dependent regulation of interferon AlphaA and interleukin-10 in the inflamed mucosa,” The Scientific World Journal, vol. 10, pp. 2167–2180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. B. Siegmund, F. Rieder, S. Albrich et al., “Adenosine kinase inhibitor GP515 improves experimental colitis in mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 296, pp. 99–105, 2001. View at Google Scholar
  58. J. G. Mabley, P. Pacher, L. Liaudet et al., “Inosine reduces inflammation and improves survival in a murine model of colitis,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 284, no. 1, pp. G138–G144, 2003. View at Google Scholar · View at Scopus
  59. B. N. Cronstein, “Adenosine, an endogenous anti-inflammatory agent,” Journal of Applied Physiology, vol. 76, no. 1, pp. 5–13, 1994. View at Google Scholar · View at Scopus
  60. G. G. Yegutkin, “Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade,” Biochimica et Biophysica Acta, vol. 1783, no. 5, pp. 673–694, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. G. Burnstock and M. Williams, “P2 purinergic receptors: modulation of cell function and therapeutic potential,” Journal of Pharmacology and Experimental Therapeutics, vol. 295, no. 3, pp. 862–869, 2000. View at Google Scholar · View at Scopus
  62. L. Antonioli, M. Fornai, O. Awwad et al., “Role of the A2B receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats,” British Journal of Pharmacology, vol. 171, pp. 1314–1329, 2014. View at Google Scholar
  63. K. D. O'Brien, C. Pineda, W. S. Chiu, R. Bowen, and M. A. Deeg, “Glycosylphosphatidylinositol-specific phospholipase D is expressed by macrophages in human atherosclerosis and colocalizes with oxidation epitopes,” Journal of the American Heart Association, vol. 99, no. 22, pp. 2876–2882, 1999. View at Publisher · View at Google Scholar
  64. G. Burnstock and S. Lavin, “Interstitial cells of Cajal and purinergic signalling,” Autonomic Neuroscience, vol. 97, no. 1, pp. 68–72, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. E. F. Diezmos, S. L. Sandow, I. Markus et al., “Expression and localization of pannexin-1 hemichannels in human colon in health and disease,” Neurogastroenterology and Motility, vol. 25, no. 6, pp. e395–e405, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. B. D. Gulbransen, M. Bashashati, S. A. Hirota et al., “Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis,” Nature Medicine, vol. 18, no. 4, pp. 600–604, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. G. J. Sanger, “New target profiling for gastrointestinal disorders: where are we going?” Current Opinion in Pharmacology, vol. 12, no. 6, pp. 629–631, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Fausther, J. Lecka, E. Soliman et al., “Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 302, no. 4, pp. 447–459, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. R. A. Cunha, “Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals,” Neurochemical Research, vol. 26, no. 8-9, pp. 979–991, 2001. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Guzman, J. G. Yu, Z. Suntres et al., “ADOA3R as a therapeutic target in experimental colitis: proof by validated high-density oligonucleotide microarray analysis,” Inflammatory Bowel Diseases, vol. 12, no. 8, pp. 766–789, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. F. L. Christofi, “Unlocking mysteries of gut sensory transmission: is adenosine the key?” News in Physiological Sciences, vol. 16, no. 5, pp. 201–207, 2001. View at Google Scholar · View at Scopus
  72. G. Cristalli, S. Costanzi, C. Lambertucci et al., “Adenosine deaminase: functional implications and different classes of inhibitors,” Medicinal Research Reviews, vol. 2, pp. 105–128, 2001. View at Google Scholar
  73. J. I. Nagy, J. D. Geiger, and W. A. Staines, “Adenosine deaminase and purinergic neuroregulation,” Neurochemistry International, vol. 16, no. 3, pp. 211–221, 1990. View at Publisher · View at Google Scholar · View at Scopus
  74. J. I. Nagy, T. Yamamoto, H. Uemura, and W. P. Schrader, “Adenosine deaminase in rodent median eminence: detection by antibody to the mouse enzyme and co-localization with adenosine deaminase-complexing protein (CD26),” Neuroscience, vol. 73, no. 2, pp. 459–471, 1996. View at Publisher · View at Google Scholar · View at Scopus
  75. J. P. J. Ungerer, H. M. Oosthuizen, S. H. Bissbort, and W. J. H. Vermaak, “Serum adenosine deaminase: isoenzymes and diagnostic application,” Clinical Chemistry, vol. 38, no. 7, pp. 1322–1326, 1992. View at Google Scholar · View at Scopus
  76. L. Antonioli, M. Fornai, R. Colucci et al., “Inhibition of adenosine deaminase attenuates inflammation in experimental colitis,” Journal of Pharmacology and Experimental Therapeutics, vol. 322, no. 2, pp. 435–442, 2007. View at Publisher · View at Google Scholar · View at Scopus